Medexus Pharmaceuticals (TSE:MDP) highlighted continued momentum for its U.S. launch of GRAFAPEX while reporting lower year-over-year revenue and earnings in its fiscal third quarter of 2026, ...
On a full-year basis, SKYRIZI and RINVOQ delivered approximately $25.9 billion in total combined revenue, an impressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results